• 1
    Sieri S, Krogh V, Pala V, Muti P, Micheli A, Evangelista A, Tagliabue G, Berrino F. Dietary patterns and risk of breast cancer in the ORDET cohort. Cancer Epidemiol Biomarkers Prev 2004; 13: 56772.
  • 2
    Mannisto S, Dixon LB, Balder HF, Virtanen MJ, Krogh V, Khani BR, Berrino F, van den Brandt PA, Hartman AM, Pietinen P, Tan F, Wolk A, et al. Dietary patterns and breast cancer risk: results from three cohort studies in the DIETSCAN project. Cancer Causes Control 2005; 16: 72533.
  • 3
    World Cancer Research Fund and American Institute for Cancer Research Food. Nutrition and the prevention of cancer: a global perspective. Washington: American Institute for Cancer Research, 1997.
  • 4
    van Gils CH, Peeters PH, Bueno-de-Mesquita HB, Boshuizen HC, Lahmann PH, Clavel-Chapelon F, Thiebaut A, Kesse E, Sieri S, Palli D, Tumino R, Panico S, et al. Consumption of vegetables and fruits and risk of breast cancer. JAMA 2005; 293: 18393.
  • 5
    Daling JR, Malone KE, Doody DR, Johnson LG, Gralow JR, Porter PL. Relation of body mass index to tumour markers and survival among young women with invasive ductal breast carcinoma. Cancer 2001; 94: 72029.
  • 6
    Zhang SM, Hankinson SE, Hunter DJ, Giovannucci EL, Colditz GA, Willett WC. Folate intake and risk of breast cancer characterized by hormone receptor status. Cancer Epidemiol Biomarkers Prev 2005; 14: 20048.
  • 7
    Althuis MD, Fergenbaum JH, Garcia-Closas M, Brinton LA, Madigan MP, Sherman ME. Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomarkers Prev 2004; 13: 155868.
  • 8
    Ménard S, Pupa SM, Campiglio M, Tagliabue E. Biologic and therapeutic role of HER2 in cancer. Oncogene 2003; 22: 65708.
  • 9
    Menard S, Balsari A, Casalini P, Tagliabue E, Campiglio M, Bufalino R, Cascinelli N. HER-2-positive breast carcinomas as a particular subset with peculiar clinical behaviors. Clin Cancer Res 2002; 8: 5205.
  • 10
    Ferrero Poüs M, Hacene K, Bouchet C, Le Doussal V, Tubiana-Hulin M, Spyratos F. Relationship between c-erbB-2 and other tumour characteristics in breast cancer prognosis. Clin Cancer Res 2000; 6: 474554.
  • 11
    Lal P, Tan LK, Chen B. Correlation of HER-2 status with estrogen and progesterone receptors and histologic features in 3,655 invasive breast carcinomas. Am J Clin Pathol 2005; 123: 5416.
  • 12
    Ross JS, Fletcher JA, Linette GP, Stec J, Clark E, Ayers M, Symmans WF, Pusztai L, Bloom KJ. The Her2/neu gene and protein in breast cancer 2003: biomarker and target of therapy. Oncologist 2003; 8: 30725.
  • 13
    Balsari A, Casalini P, Bufalino R, Berrino F, Ménard S. Role of hormonal risk factors in HER2-positive breast carcinomas. Br J Cancer 2003; 88: 10324.
  • 14
    Kleibaum DG, Kupper LL, Muller KE. Applied regression analysis and other multivariate methods. Pacific Grove, CA: Duxbury, 1988.
  • 15
    Cattell RB. The scree test for the number of factors. Multivariate Behav Res 1966; 1: 24576.
  • 16
    Italian Network for Quality Assurance of Tumor Biomarkers (INQAT) Group. Interobserver reproducibility of immunohistochemical HER-2/neu assessment in human breast cancer: an update from INQAT round III. Int J Biol Markers 2005; 3: 18994.
  • 17
    Hosmer DW, Lemeshow S. Applied logistic regression, 2nd edn. New York: Wiley, 2001.
  • 18
    Stata Corporation. Stata statistical software: release 7.0. College Station, TX: Stata Corporation, 2001.
  • 19
    Borek C. Dietary antioxidants and human cancer. Integr Cancer Ther 2004; 3: 33341.
  • 20
    Mondello C, Guasconi V, Giulotto E, Nuzzo F. Gamma-ray and hydrogen peroxide induction of gene amplification in hamster cells deficient in DNA double strand break repair. DNA Repair (Amst) 2002; 1: 48393.
  • 21
    Kim YI. Folate and carcinogenesis: evidence, mechanisms, and implications. J Nutr Biochem 1999; 2: 6688.
  • 22
    Melnyk S, Pogribna M, Miller BJ, Basnakian AG, Pogribny IP, James SJ. Uracil misincorporation, DNA strand breaks, and gene amplification are associated with tumorigenic cell transformation in folate deficient/repleted Chinese hamster ovary cells. Cancer Lett 1999; 146: 3544.
  • 23
    Singletary KW, Gapstur SM. Alcohol and breast cancer: review of epidemiologic and experimental evidence and potential mechanisms. JAMA 2001; 286: 214351.
  • 24
    Menendez JA, Vellon L, Colomer R, Lupu R. Oleic acid, the main monounsaturated fatty acid of olive oil, suppresses Her-2/neu (erbB-2) expression and synergistically enhances the growth inhibitory effects of trastuzumab (Herceptin) in breast cancer cells with Her-2/neu oncogene amplification. Ann Oncol 2005; 16: 35971.
  • 25
    Moral R, Solanas M, Garcia G, Colomer R, Escrich E. Modulation of EGFR and neu expression by n-6 and n-9 high-fat diets in experimental mammary adenocarcinomas. Oncol Rep 2003; 10: 141724.